期刊
JOURNAL OF CLINICAL MEDICINE
卷 11, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/jcm11113035
关键词
quality of life; heart failure; older patients; prognosis
资金
- Fundacion MAPFRE, grant Primitivo de la Vega
Information about health-related quality of life (HRQoL) in heart failure (HF) in older adults is limited. This study described the HRQoL of a cohort of older patients with recent HF hospitalization who received multidisciplinary intervention by a geriatrician and a cardiologist compared to a control group who received intervention by a cardiologist alone. The results showed that almost half of the patients had impaired HRQoL, and those with worse HRQoL had higher mortality and hospitalization rates.
Background: Information about health-related quality of life (HRQoL) in heart failure (HF) in older adults is scarce. Methods: We aimed to describe the HRQoL of the SENECOR study cohort, a single-center, randomized trial comparing the effects of multidisciplinary intervention by a geriatrician and a cardiologist (intervention group) to that of a cardiologist alone (control group) in older patients with a recent HF hospitalization. Results: HRQoL was assessed by the short version of the disease-specific Kansas Cardiomyopathy Questionnaire (KCCQ-12) in 141 patients at baseline and was impaired (KCCQ-12 < 75) in almost half of the cohort. Women comprised 50% of the population, the mean age was 82.2 years, and two-thirds of patients had preserved ejection fraction. Comorbidities were highly prevalent. Patients with impaired HRQoL had a worse NYHA functional class, a lower NT-proBNP, a lower Barthel index, and a higher Clinical Frailty Scale. One-year all-cause mortality was 22.7%, significantly lower in the group with good-to-excellent HRQoL (14.5% vs. 30.6%; hazard ratio 0.28; 95% confidence interval 0.10-0.78; p = 0.014). In the group with better HRQoL, all-cause hospitalization was lower, and there was a trend towards lower HF hospitalization. Conclusions: The KCCQ-12 questionnaire can provide inexpensive prognostic information even in older patients with HF. (Funded by grant Primitivo de la Vega, Fundacion MAPFRE. ClinicalTrials number, NCT03555318).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据